# OnCo record suzhou-bluehorse-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/suzhou-bluehorse-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "suzhou-bluehorse-therapeutics" ;
  schema:name "Suzhou BlueHorse Therapeutics"@en ;
  schema:alternateName "Suzhou Lanma Biotechnology"@en ;
  schema:description "Suzhou BlueHorse Therapeutics is a China-based cell therapy company that leads 2 cancer trials in OnCo, testing the tumour-infiltrating lymphocyte product LM103 in non-small-cell lung cancer and melanoma."@en ;
  schema:url <https://onco.cc/companies/suzhou-bluehorse-therapeutics/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?lead=Suzhou%20BlueHorse%20Therapeutics%20Co.%2C%20Ltd.> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/melanoma/> ;
  onco:drugs <https://onco.cc/drugs/dacarbazine/>, <https://onco.cc/drugs/temozolomide/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/cisplatin/> ;
  onco:trials <https://onco.cc/trials/nct07444437/>, <https://onco.cc/trials/nct07310784/> .